Condition
Colon, Irritable
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (2)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06291272Not ApplicableCompletedPrimary
Effect of Methylcellulose or Psyllium on Fermentation of inUlin Assessed USing MRI
NCT01072916CompletedPrimary
Serine Proteases in Gastrointestinal Function and Irritable Bowel Syndrome (IBS)
NCT01887834Phase 1Completed
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome
NCT01072903Completed
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
NCT01176227Phase 1Completed
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)
Showing all 5 trials